---
figid: PMC6104680__annrheumdis-2018-213031f06
figtitle: Mechanisms of interaction between IL-6 and TGFB leading to fibrosis in SSc
organisms:
- NA
pmcid: PMC6104680
filename: annrheumdis-2018-213031f06.jpg
figlink: /pmc/articles/PMC6104680/figure/F6/
number: F6
caption: Potential mechanisms of interaction between IL-6 and TGFβ leading to fibrosis
  in SSc. (1) Inflammatory macrophage-produced IL-6 enhances fibrogenic macrophage
  function (potential TCZ target). (2) IL-6 induces TGFβ production and enhances its
  signalling in fibroblasts (potential TCZ target). (3) TGFβ enhances IL-6 production
  by fibroblasts. (4) IL-6 directly activates fibroblasts to produce profibrotic proteins
  such as Col1 (potential TCZ target). (5) TGFβ directly induces fibroblast differentiation
  into myofibroblasts. (6) Intracellularly, IL-6 classic signalling and TGFβ alternative
  signalling converge towards the activation of STAT3 (STAT3 → P-STAT3) resulting
  in aberrant expression of STAT3-dependent genes. αSMA, alpha-smooth muscle actin;
  Col1, collagen alpha 1; CTGF, connective tissue growth factor; ECM, extracellular
  matrix; GF, growth factor; IL-6, interleukin-6; JAK, Janus-activated kinase; JNK,
  Jun N-terminal kinase; P-STAT, phosphorylated STAT; STAT, signal transducer and
  activator of transcription; TGFβ, transforming growth factor beta; TGFβR, transforming
  growth factor beta receptor; TYK, tyrosine kinase.
papertitle: 'Therapeutic interleukin-6 blockade reverses transforming growth factor-beta
  pathway activation in dermal fibroblasts: insights from the faSScinate clinical
  trial in systemic sclerosis.'
reftext: Christopher P Denton, et al. Ann Rheum Dis. 2018 Sep;77(9):1362-1371.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8653052
figid_alias: PMC6104680__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6104680__F6
ndex: e8becd00-defa-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6104680__annrheumdis-2018-213031f06.html
  '@type': Dataset
  description: Potential mechanisms of interaction between IL-6 and TGFβ leading to
    fibrosis in SSc. (1) Inflammatory macrophage-produced IL-6 enhances fibrogenic
    macrophage function (potential TCZ target). (2) IL-6 induces TGFβ production and
    enhances its signalling in fibroblasts (potential TCZ target). (3) TGFβ enhances
    IL-6 production by fibroblasts. (4) IL-6 directly activates fibroblasts to produce
    profibrotic proteins such as Col1 (potential TCZ target). (5) TGFβ directly induces
    fibroblast differentiation into myofibroblasts. (6) Intracellularly, IL-6 classic
    signalling and TGFβ alternative signalling converge towards the activation of
    STAT3 (STAT3 → P-STAT3) resulting in aberrant expression of STAT3-dependent genes.
    αSMA, alpha-smooth muscle actin; Col1, collagen alpha 1; CTGF, connective tissue
    growth factor; ECM, extracellular matrix; GF, growth factor; IL-6, interleukin-6;
    JAK, Janus-activated kinase; JNK, Jun N-terminal kinase; P-STAT, phosphorylated
    STAT; STAT, signal transducer and activator of transcription; TGFβ, transforming
    growth factor beta; TGFβR, transforming growth factor beta receptor; TYK, tyrosine
    kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - IL6
  - IL6R
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - JAK2
  - STAT3
  - JAK1
  - MAPK8
  - MAPK9
  - MAPK10
  - TYK2
  - ABL1
  - SRC
  - FGR
  - FYN
  - YES1
  - EDC4
  - CCN2
  - COL1A1
  - COL1A2
  - ACTA1
---
